SciB logo_Mar 2025

Therapeutics and Modalities

Subscribe for all things therapeutics

Therapeutics and Modalities Blog Posts

People with question marks above their heads

What is data exclusivity?

Read More
Image of rubber stamp FDA approved and title Orange book and purple book

The Orange Book and Purple Book

Read More

Therapeutics at the FDA: paths to approval

Read More
BLA text with checkmark

2023 Year in Review:  approved BLAs

Read More
image with check mark and the text NDA

2023 Year in Review:  approved NDAs

Read More
Image with three icons showing a person running with an arrow trending up

Biosimilar Therapeutics: generics of biologic drugs

Read More
Letters ANDA beside a mountain

Therapeutic FDA approvals: the rise of the ANDA

Read More
image of FDA building

Therapeutics in the U.S.: why are there NDAs and BLAs? 

Read More
Image with icons of needle, syringe, pill bottle, and building with CDER, CBER and FDA text

Approval and Regulation of Therapeutics and Modalities at the FDA

Read More

Therapeutics and Modalities: at the intersection of science and investing

Read More
A circle divided into the five therapeutic classes of small molecules, large molecules, gene therapy, cell therapy, and RNA therapy

Therapeutics and Modalities 101

Read More
LEGAL Notice: I am not a licensed financial advisor. I offer education, not prescriptive advice. The information that is found here are my opinions. I also do not give any type of legal advice and the information herein should not be considered legal advice or create an attorney-client relationship.

Copyright © 2024 Science For Bankers

Scroll to Top